Citigroup »

Denali Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 141k 21.46
2023-09-30 $2.9M 138k 20.63
2023-03-31 $4.8M 208k 23.04
2022-12-31 $3.6M 128k 27.81
2022-09-30 $6.9M 193k 35.71
2021-12-31 $5.4M 120k 44.60
2021-03-31 $4.0M 70k 57.10
2020-12-31 $1.5M 18k 83.77
2020-09-30 $249k 6.9k 35.86
2020-06-30 $0 50k 0.00
2020-03-31 $663k 38k 17.51
2019-12-31 $305k 18k 17.41
2019-09-30 $1.2M 79k 15.32
2019-06-30 $1.3M 65k 20.76
2019-03-31 $279k 12k 23.27
2018-12-31 $1.8M 89k 20.66
2018-09-30 $279k 13k 21.73
2018-06-30 $37k 2.4k 15.25
2018-03-31 $45k 2.3k 19.64